Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maher Albitar

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Archives of Pathology & Laboratory Medicine|July 8, 2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimensAziza Nassar, Cynthia Cohen, Sally S Agersborg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndromeRazelle Kurzrock, Maher Albitar, Jorge E Cortes, et al.
British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Pancreas|June 28, 2011
Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic massesSofiya Reicher, Fatih Z Boyar, Maher Albitar, et al.
Blood|August 27, 2005
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemiaStefan Faderl, Kim-Anh Do, Marcella M Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemiaWilliam Wierda, Susan O'Brien, Sijin Wen, et al.
Leukemia Research|August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phaseFrancis J Giles, Eric J Feldman, Gail J Roboz, et al.
Blood|August 28, 2009
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapseFrancis Giles, Norbert Vey, Daniel DeAngelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responsesJorge E Cortes, Hagop M Kantarjian, Stuart L Goldberg, et al.
The American Journal of Pathology|October 15, 2022
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial IntelligenceHong Zhang, Muhammad A Qureshi, Mohsin Wahid, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Archives of Pathology & Laboratory Medicine|July 8, 2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimensAziza Nassar, Cynthia Cohen, Sally S Agersborg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndromeRazelle Kurzrock, Maher Albitar, Jorge E Cortes, et al.
British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Pancreas|June 28, 2011
Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic massesSofiya Reicher, Fatih Z Boyar, Maher Albitar, et al.
Blood|August 27, 2005
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemiaStefan Faderl, Kim-Anh Do, Marcella M Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemiaWilliam Wierda, Susan O'Brien, Sijin Wen, et al.
Leukemia Research|August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phaseFrancis J Giles, Eric J Feldman, Gail J Roboz, et al.
Blood|August 28, 2009
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapseFrancis Giles, Norbert Vey, Daniel DeAngelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responsesJorge E Cortes, Hagop M Kantarjian, Stuart L Goldberg, et al.
The American Journal of Pathology|October 15, 2022
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial IntelligenceHong Zhang, Muhammad A Qureshi, Mohsin Wahid, et al.
Pageof 22